MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Lipoproteins and Cardiovascular Health
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,195 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,195 works in the cohort · of 4,299,418page 9 of 64

Labels cover 13 of 3,195 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,195 of 3,195 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundunlabeled
Loss- and Gain-of-function PCSK9 Variants
Suzanne Benjannet, Josée Hamelin, Michel Chrétien, Nabil G. Seidah
2012· article· en· Journal of Biological Chemistry· Medicine
distilled prediction:candidate · noneconsensus · none
82
citations
affno abstractunlabeled
Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronary Heart Disease††Conflicts of interest: Dr. Conard served as a consultant and advisor for Merck & Company and Merck/Schering-Plough. Dr. Bays received research grants from Amylin, San Diego, California, Amgen, Thousand Oaks, California, J&J, Langhorne, Pennsylvania, Aegerion, Bridgewater, New Jersey, Abbott, Chicago, Illinois, Arena Pharmaceuticals, San Diego, California, GlaxoSmithKline (Glaxo), London, UK, Hoffmann LaRoche, Nutley, New Jersey, Merck, Whitehouse Station, New Jersey, MSP, Kenilworth, New Jersey, Metabolex, San Jose, California, Schering-Plough, Kenilworth, New Jersey, Orexigen, San Diego, California, Reliant, Liberty Corner, New Jersey, Sciele, Atlanta, Georgia, Takeda, Osaka, Japan, TAP, Lake Forest, Illinois, and Vivus, Mountain View, California; received speakers' honoraria from Abbott, Daiichi Sankyo, Tokyo, Japan, GlaxoSmithKline, Reliant, Merck & Company, Merck/Schering-Plough, and Schering-Plough; received honoraria from Abbott, AstraZeneca, London, UK (Wilmington, Delaware, US Headquarters), Daiichi Sankyo, GlaxoSmithKline, Reliant, Merck & Company, Merck/Schering-Plough, and Schering-Plough; and served as a consultant and advisor for Abbott, GlaxoSmithKline, Metabolex, San Jose, California, Reliant, Takeda, AstraZeneca, and Essentialis, Carlsbad, California. Dr. Leiter received grants and speakers' honoraria from and served as a consultant and advisor for AstraZeneca, Merck & Company, Merck/Schering-Plough, and Pfizer, New York, New York. Mr. Bird, Mr. Rubino, and Drs. Lowe, Tomassini, and Tershakovec are employees of Merck & Company and may own stock and/or hold stock options in the company.
Scott Conard, Harold Bays, Lawrence A. Leiter, Steven Bird, Joseph Rubino, Robert S. Lowe +2 more
2008· article· en· The American Journal of Cardiology· Medicine
distilled prediction:candidate · metaepi_narrow+sts+research_integrityconsensus · metaepi_narrow+sts+research_integrity
81
citations
affunlabeled
Safety Profile of Extended-Release Niacin in the AIM-HIGH Trial
Todd J. Anderson, William E. Boden, Patrice Desvigne‐Nickens, Jerome L. Fleg, Moti L. Kashyap, Ruth McBride +1 more
2014· letter· en· New England Journal of Medicine· Medicine
distilled prediction:candidate · research_integrityconsensus · none
79
citations
affno abstractunlabeled
Using Age- and Sex-Specific Risk Thresholds to Guide Statin Therapy
Ann Marie Navar‐Boggan, Eric D. Peterson, Ralph B. D’Agostino, Michael Pencina, Allan D. Sniderman
2015· article· en· Journal of the American College of Cardiology· Medicine
distilled prediction:candidate · noneconsensus · none
74
citations
← previousnext →

How this was built: Screen · Findings · About